Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Sara De Carolis, Sara Tabacco

Risultato della ricerca: Contributo in rivistaArticolo in rivista

2 Citazioni (Scopus)

Abstract

We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.
Lingua originaleEnglish
pagine (da-a)711-712
Numero di pagine2
RivistaAmerican Journal of Obstetrics and Gynecology
Volume217
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Antibodies, Antiphospholipid
  • Antiphospholipid Syndrome
  • Female
  • Humans
  • Hydroxychloroquine
  • Obstetrics and Gynecology
  • Pregnancy

Fingerprint Entra nei temi di ricerca di 'Hydroxychloroquine as additional treatment in pregnant patients with refractory APS'. Insieme formano una fingerprint unica.

Cita questo